To explore the mechanism by which GCN5L1 levels alter HCC development and proliferation and the role of GLS1/GLS2 in HCC cell proliferation and glutamine addiction, we first measured glutaminase activity in GCN5L1‐deleted HepG2 cells. The gene discussed is BLOC1S1; the disease is hepatocellular carcinoma.